SCHEMBL28238230

SCHEMBL28238230

CC=CCc1ccc(N2CCOCC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ L3MBTL1 Q9Y468 3/20 0.49
▸ GAA P10253 3/20 0.49
▸ MAPT P10636 9/20 0.49
▸ ALDH1A1 P00352 7/20 0.49
▸ KDM4E B2RXH2 5/20 0.49
▸ MEN1 O00255 5/20 0.49
▸ KMT2A Q03164 5/20 0.49
▸ ALOX15 P16050 3/20 0.49
▸ HTT P42858 3/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ AGXT P21549 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ LMNA P02545 4/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ ALOX12 P18054 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propene SCHEMBL11669284 0.81 RAB9A (0.48) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL1701348 0.79 PIK3CD (0.51) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL27870814 0.79 RAB9A (0.49) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL5712027 0.78 MAPT (0.48) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL5758053 0.77 LMNA (0.52) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL39888 0.77 LMNA (0.52) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL178277 0.77 MAPT (0.60) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL1714777 0.76 AGXT (0.69) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL16003056 0.76 MAPT (0.58) RAB9ANPC1L3MBTL1GAAMAPT
SCHEMBL9093746 0.76 LMNA (0.71) RAB9ANPC1MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104710327-B It is beneficial to treat the compound of central nervous system disease and illness 奥里梅德制药公司 2018-09-07 — — CN disclosed
Send feedback